Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis
Bradley J. Langford, Miranda So, Sumit Raybardhan, et al.
Clinical Microbiology and Infection (2020) Vol. 26, Iss. 12, pp. 1622-1629
Open Access | Times Cited: 1430

Showing 1-25 of 1430 citing articles:

Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19
Yun Kit Yeoh, Tao Zuo, Grace Lui, et al.
Gut (2021) Vol. 70, Iss. 4, pp. 698-706
Open Access | Times Cited: 1096
Towards the sustainable discovery and development of new antibiotics
Marcus Miethke, Marco Pieroni, Tilmann Weber, et al.
Nature Reviews Chemistry (2021) Vol. 5, Iss. 10, pp. 726-749
Open Access | Times Cited: 780
Antibiotic prescribing in patients with COVID-19: rapid review and meta-analysis
Bradley J. Langford, Miranda So, Sumit Raybardhan, et al.
Clinical Microbiology and Infection (2021) Vol. 27, Iss. 4, pp. 520-531
Open Access | Times Cited: 733
Antibiotic resistance: The challenges and some emerging strategies for tackling a global menace
David Chinemerem Nwobodo, Malachy Ugwu, Clement Oliseloke Anie, et al.
Journal of Clinical Laboratory Analysis (2022) Vol. 36, Iss. 9
Open Access | Times Cited: 462
A Mini Review of Antibacterial Properties of ZnO Nanoparticles
Sergey V. Gudkov, Dmitriy E. Burmistrov, Dmitriy A. Serov, et al.
Frontiers in Physics (2021) Vol. 9
Open Access | Times Cited: 409
Empiric Antibacterial Therapy and Community-onset Bacterial Coinfection in Patients Hospitalized With Coronavirus Disease 2019 (COVID-19): A Multi-hospital Cohort Study
Valerie M. Vaughn, Tejal Gandhi, Lindsay A Petty, et al.
Clinical Infectious Diseases (2020) Vol. 72, Iss. 10, pp. e533-e541
Open Access | Times Cited: 366
Hospital-Acquired Infections in Critically Ill Patients With COVID-19
Giacomo Grasselli, Vittorio Scaravilli, Davide Mangioni, et al.
CHEST Journal (2021) Vol. 160, Iss. 2, pp. 454-465
Open Access | Times Cited: 317
Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP-UK study: a multicentre, prospective cohort study
Clark D Russell, Cameron J Fairfield, Thomas M Drake, et al.
The Lancet Microbe (2021) Vol. 2, Iss. 8, pp. e354-e365
Open Access | Times Cited: 291
Antimicrobial resistance and COVID-19: Intersections and implications
Gwenan M. Knight, R. E. Glover, Christopher Finn McQuaid, et al.
eLife (2021) Vol. 10
Open Access | Times Cited: 281
The role of co-infections and secondary infections in patients with COVID-19
Charles Feldman, Ronald Anderson
Pneumonia (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 275
Azithromycin for community treatment of suspected COVID-19 in people at increased risk of an adverse clinical course in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial
Christopher Butler, Jienchi Dorward, Ly‐Mee Yu, et al.
The Lancet (2021) Vol. 397, Iss. 10279, pp. 1063-1074
Open Access | Times Cited: 272
Nosocomial infections associated to COVID-19 in the intensive care unit: clinical characteristics and outcome
Tommaso Bardi, Vicente Pintado, María Gómez Rojo, et al.
European Journal of Clinical Microbiology & Infectious Diseases (2021) Vol. 40, Iss. 3, pp. 495-502
Open Access | Times Cited: 265
Time-resolved systems immunology reveals a late juncture linked to fatal COVID-19
Can Liu, Andrew J. Martins, William Lau, et al.
Cell (2021) Vol. 184, Iss. 7, pp. 1836-1857.e22
Open Access | Times Cited: 207
Management of hospitalised adults with coronavirus disease 2019 (COVID-19): a European Respiratory Society living guideline
James D. Chalmers, Megan Crichton, Pieter Goeminne, et al.
European Respiratory Journal (2021) Vol. 57, Iss. 4, pp. 2100048-2100048
Open Access | Times Cited: 201
Recommendations for antibacterial therapy in adults with COVID-19 – an evidence based guideline
Elske Sieswerda, Mark de Boer, Marc J. M. Bonten, et al.
Clinical Microbiology and Infection (2020) Vol. 27, Iss. 1, pp. 61-66
Open Access | Times Cited: 191
NF-κB Pathway as a Potential Target for Treatment of Critical Stage COVID-19 Patients
Ralf Kircheis, Emanuel Haasbach, Daniel Lueftenegger, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 186
The role of C-reactive protein as a prognostic marker in COVID-19
Dominic Stringer, Philip Braude, Phyo Kyaw Myint, et al.
International Journal of Epidemiology (2021) Vol. 50, Iss. 2, pp. 420-429
Open Access | Times Cited: 177
Gut microbiota in COVID-19: key microbial changes, potential mechanisms and clinical applications
Fen Zhang, Raphaela Iris Lau, Qin Liu, et al.
Nature Reviews Gastroenterology & Hepatology (2022) Vol. 20, Iss. 5, pp. 323-337
Open Access | Times Cited: 177
COVID-19 increased the risk of ICU-acquired bloodstream infections: a case–cohort study from the multicentric OUTCOMEREA network
Niccolò Buetti, Stéphane Ruckly, Étienne de Montmollin, et al.
Intensive Care Medicine (2021) Vol. 47, Iss. 2, pp. 180-187
Open Access | Times Cited: 167
Will coronavirus disease (COVID-19) have an impact on antimicrobial resistance?
Dominique L Monnet, Stephan Harbarth
Eurosurveillance (2020) Vol. 25, Iss. 45
Open Access | Times Cited: 163
Confronting antimicrobial resistance beyond the COVID-19 pandemic and the 2020 US election
Steffanie A. Strathdee, Sally C. Davies, Jasmine R Marcelin
The Lancet (2020) Vol. 396, Iss. 10257, pp. 1050-1053
Open Access | Times Cited: 159
The interface between COVID-19 and bacterial healthcare-associated infections
Ronan O’Toole
Clinical Microbiology and Infection (2021) Vol. 27, Iss. 12, pp. 1772-1776
Open Access | Times Cited: 156
Antimicrobial resistance (AMR) in COVID-19 patients: a systematic review and meta-analysis (November 2019–June 2021)
Ruwandi Kariyawasam, Danielle Julien, Dana C. Jelinski, et al.
Antimicrobial Resistance and Infection Control (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 156
Secondary Infections in Hospitalized COVID-19 Patients: Indian Experience
Sonam Vijay, N.K. Bansal, Brijendra Kumar Rao, et al.
Infection and Drug Resistance (2021) Vol. Volume 14, pp. 1893-1903
Open Access | Times Cited: 152
Few bacterial co-infections but frequent empiric antibiotic use in the early phase of hospitalized patients with COVID-19: results from a multicentre retrospective cohort study in The Netherlands
Zara Karami, Bram T. Knoop, Anton S. M. Dofferhoff, et al.
Infectious Diseases (2020) Vol. 53, Iss. 2, pp. 102-110
Open Access | Times Cited: 150
Page 1 - Next Page

Scroll to top